ÂÜÀòÂÒÂ×

Colin Keating is an accomplished executive with extensive experience in biotechnology, consulting, and investment management. Currently serving as Chief Executive Officer of Microbio, an Australian biotechnology scale-up revolutionizing pathogen detection, Colin previously held leadership roles such as Director at Tayan Chalier Consulting, where assistance was provided to boards and senior management for business improvement and corporate transactions. As Founder and Director of CTC Bloodstock, Colin established a managed investment fund focusing on the thoroughbred industry. Colin’s experience also includes significant positions at MindBio Therapeutics, Zanda Partners, buyMyplace.com.au, and Powerwrap Limited, along with Managing Director roles at HRG and Fraedom, where responsibilities spanned operational performance, strategy development, and P&L management. Prior to these roles, Colin served as Global Account Director at American Express Business Travel.